IP Library Granted Patent US 8,119,366
Granted Patent B2
US 8,119,366 · App. 12/245,518 · Granted Feb 21, 2012

Antennapedia-dominant negative mastermind-like construct

Assignee: Trojan Technologies, Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,119,366
App. No.
12/245,518
Granted
Feb 21, 2012
Kind
B2
Abstract

The present invention is based on the discovery that the Notch signaling pathway is associated with cancer. Accordingly, the invention provides methods and compositions for treating cancer. Also provided are methods of modulating the expression and/or activity of proteins in the Notch signaling pathway for use in diagnoses and treatment of cancer in a subject.

Claims (6)

1. A nucleic acid construct encoding a fusion protein comprising the amino acid sequence of SEQ ID NO:2.

2. The nucleic acid construct of claim 1 , wherein the nucleic acid construct is in a vector.

3. An isolated host cell containing a vector of claim 2 .

4. The host cell of claim 3 , wherein the host cell is E. coli.

5. A method of producing a protein encoded by the nucleic construct of claim 1 , comprising transfecting the construct to an isolated host cell thereby producing the protein in the host cell.

6. The method of claim 5 , wherein the host cell is E. coli.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2017
From: TROJAN TECHNOLOGIES LIMITED
To: ANASTASIS BIOTEC LIMITED
Reel/Frame 043637/0298 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2009
From: STYLIANOU, SPYROS
To: TROJAN TECHNOLOGIES, LTD.
Reel/Frame 022215/0368 →
Continuity (3)
Provisional Application 60978039 · Oct 5, 2007
Provisional Application 61044215 · Apr 11, 2008
Related Publication 20090137470A1 · May 28, 2009